header advert
Orthopaedic Proceedings Logo

Receive monthly Table of Contents alerts from Orthopaedic Proceedings

Comprehensive article alerts can be set up and managed through your account settings

View my account settings

Visit Orthopaedic Proceedings at:

Loading...

Loading...

Full Access

O1053 RADICULOPATHY AND MIELOPATHY AT SEGMENTS ADJACENT TO THE SITE OF A PREVIOUS ANTERIOR CERVICAL ARTHRODESIS – 85 CASES REVIEW



Abstract

Aims: It is believed that arthrodesis of spinal segments leads to excessive stress at unfused adjacent levels. The incidence, prevalence and radiographic progression of symptomatic adjacent-segment disease were studied. Methods: A series of 85 patients who had an anterior cervical arthrodesis for the treatment of cervical spondylosis with radiculopathy or mielopathy were reviewed with a minimum of 7 months and a maximum of ten year follow-up. The annual incidence of adjacent-segment disease was defined as the percentage of patients who had been disease-free at the start of a given year of follow-up in whom new disease developed during that year. The prevalence was defined as the percentage of all patients in whom symptomatic adjacent-segment disease developed within a given period of follow-up. The hypothesis that new disease at an adjacent level is more likely to develop following multilevel arthrodesis was also tested. Results: Symptomatic adjacent-level disease occurred at an incidence of 5,3% per year, with an 18,2% maximum at the third year of follow-up and a final prevalence of 34,1%. The greatest risk of new disease was at the interspaces of the sixth and seventh cervical vertebrae. Patients with a multilevel arthodesis were significantly more likely to have symptomatic adjacent-level disease. Conclusions: Symptomatic adjacent-segment disease may affect more than one-third of all patients within ten years after an anterior cervical arthrodesis. A multilevel arthrodesis and the interspaces between the sixth and seventh cervical vertebrae appear to be the greatest risk factors for new disease...

Theses abstracts were prepared by Professor Dr. Frantz Langlais. Correspondence should be addressed to him at EFORT Central Office, Freihofstrasse 22, CH-8700 Küsnacht, Switzerland.